Drug Trial Radar · NCT03393819
Efficacy of Surgical Skin Preparation Solutions in Hip Arthroplasty Surgery
Last checked: Nov 20, 2026Latest source record: Jul 1, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
105
Actual
Start
Oct 29, 2014
Primary completion
Jan 7, 2016
Study completion Apr 6, 2016
Sponsor
- Lead sponsor
- Lakehead UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Thunder Bay Regional Health Sciences Centre
- First posted
- Jan 9, 2018
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will assess the efficacy of two of the most commonly used surgical skin-preparation solutions: Chloraprep (chlorhexidine-alcohol) and Duraprep (iodine-alcohol) at eliminating bacteria from the hip site by evaluating the residual bacteria present following surgical skin-preparation.
Conditions
- Arthroplasty, Hip Replacement
- Infection, Postoperative Wound
Interventions
DuraPrepDrug
DuraPrep surgical solution
ChloraPrepDrug
ChloraPrep surgical solution
Primary outcomes
What the sponsor says the trial is designed to measure.
- Post-preparation skin swabTime frame: 4 minutes post-skin preparation
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.